MedPath

Comparison between the clinical efficacy of linagliptin and sitaglipti

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000010998
Lead Sponsor
Toyota Kosei Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. < 20 year-old or 80 year old => 2. Cr>3.0mg/dl or eGFR<15ml/min 3. Pregnant or possibly pregnant women and women on lactation 4. allergy to DPP-4 inhibitors 5. poor control,HbA1c(NGSP) 8.5% => and patients who were thought as inadequate for this study by doctor in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath